Cadrenal Therapeutics, Inc. (CVKD)
4.70
-0.20
(-4.08%)
USD |
NASDAQ |
Apr 02, 16:00
4.74
+0.04
(+0.85%)
After-Hours: 20:00
Cadrenal Therapeutics Shareholders Equity (Quarterly) : 2.739M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 245.15M |
| Dyadic International, Inc. | 1.232M |
| Phio Pharmaceuticals Corp. | 20.15M |
| Jaguar Health, Inc. | 5.627M |
| MetaVia, Inc. | 5.333M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.327M |
| Total Liabilities (Quarterly) | 1.588M |
| Current Ratio | 2.653 |
| Net Debt Paydown Yield | 0.00% |